Jumbophage PCH45 evades type I, but not type III, CRISPR-Cas immunity.
Por um escritor misterioso
Descrição
Jumbo phage PCH45 evades type I, but not type III, CRISPR–Cas
The jumbo phage is resistant to type I CRISPR-Cas immunity a. tblastx
Viral speciation through subcellular genetic isolation and virogenesis incompatibility
Degradation of Phage Transcripts by CRISPR-Associated RNases Enables Type III CRISPR-Cas Immunity: Cell
Jumbophage infection is inhibited by the type III CRISPR-Cas system. A.
Intracellular Organization by Jumbo Bacteriophages
A cytoskeletal vortex drives phage nucleus rotation during jumbo phage replication in E. coli - ScienceDirect
Jumbo phage PCH45 evades type I, but not type III, CRISPR–Cas
A type III-A CRISPR-Cas system employs degradosome nucleases to ensure robust immunity
A jumbo phage that forms a nucleus-like structure evades CRISPR–Cas DNA targeting but is vulnerable to type III RNA-based immunity
Frontiers The Phage Nucleus and PhuZ Spindle: Defining Features of the Subcellular Organization and Speciation of Nucleus-Forming Jumbo Phages
Type III CRISPR–Cas provides resistance against nucleus-forming jumbo phages via abortive infection
A cytoskeletal vortex drives phage nucleus rotation during jumbo phage replication in E. coli - ScienceDirect
